Related Experiment Video
Updated: Apr 19, 2026
06:12
Production of Genetically Engineered Golden Syrian Hamsters by Pronuclear Injection of the CRISPR/Cas9 Complex
Published on: January 9, 2018
14.0K
[Establishment and application of human CHO/NTR1 system]
Yao Xue Xue Bao = Acta Pharmaceutica Sinica
|December 19, 2014
Summary
Researchers developed a new cell line to screen for cancer drugs targeting neurotensin receptor-1 (NTR1). This G-protein coupled receptor plays a role in disease development, and the cell line aids in identifying potential NTR1 inhibitors.
Area of Science:
- Pharmacology
- Molecular Biology
- Cell Biology
Background:
- Neurotensin receptor-1 (NTR1) is a G-protein coupled receptor involved in intracellular signaling.
- NTR1 is implicated in the pathogenesis of various diseases, including cancers.
- Targeting NTR1 is a potential therapeutic strategy for NTR1-associated diseases.
Purpose of the Study:
- To establish a robust cell line for screening NTR1 inhibitors.
- To create a Chinese hamster ovary (CHO) cell line overexpressing human NTR1 (hNTR1).
- To validate the functionality of the established cell line for drug discovery.
Main Methods:
- Construction of a recombinant plasmid containing the hNTR1 gene.
- Transfection of the plasmid into CHO cells, followed by G418 selection.
- Validation using Western blotting and calcium flux assays on FlexStation 3.
Main Results:
- Successful establishment of a stable CHO cell line expressing high levels of hNTR1.
- Demonstrated NTR1 functionality through calcium flux assays.
- Determined EC50 for the NTR1 agonist neurotensin peptide and IC50 for the antagonist SR48692.
Conclusions:
- The developed CHO/NTR1 cell line is a valuable tool for studying NTR1 biological activity.
- This cell line facilitates the screening and identification of novel NTR1 antagonists and agonists.
- The platform supports the development of targeted therapies for NTR1-related diseases.
